Cognitive Behavioral Therapy for Body Image Distress in Head and Neck Cancer Survivors
(BRIGHT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new video-based therapy called BRIGHT, designed to help head and neck cancer survivors with body image issues. Participants will be randomly assigned to either the BRIGHT therapy, which uses cognitive behavioral techniques, or a supportive care group that provides attention and care without focusing on body image. The goal is to determine if BRIGHT can improve participants' body image and overall quality of life. Ideal candidates for this trial have had head or neck cancer, completed treatment within the last year, and are cancer-free but still experience significant body image distress. As an unphased trial, this study offers a unique opportunity to explore innovative therapy methods that could significantly enhance quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have started or adjusted psychotropic medication in the last 3 months, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the BRIGHT program, a form of cognitive behavioral therapy (CBT), is safe and well-received by head and neck cancer survivors dealing with body image issues. Studies have found that this video-based therapy is accepted by patients and helps improve their emotional health. These studies have reported no major safety problems. The therapy involves discussing feelings and thoughts with a psychologist and has proven effective for many without causing harmful effects.12345
Why are researchers excited about this trial?
Researchers are excited about the BRIGHT treatment because it offers a new approach to managing body image distress in head and neck cancer survivors. Unlike traditional therapies that might focus on general psychological support, BRIGHT uses a specialized video tele-cognitive behavioral therapy (CBT) delivered one-on-one by a licensed clinical psychologist. This approach is unique because it specifically targets the psychological aspects of body image issues through a structured, theory-based method, potentially providing more tailored and effective support for survivors. Additionally, its delivery via video telehealth offers greater accessibility and convenience, which is crucial for individuals who may have mobility or transportation challenges.
What evidence suggests that BRIGHT could be an effective treatment for body image distress in head and neck cancer survivors?
Research has shown that the BRIGHT program, a form of cognitive behavioral therapy (CBT), can reduce distress about body image in head and neck cancer survivors. In this trial, some participants will receive the BRIGHT intervention, which studies have found significantly improves patients' feelings about their appearance after cancer treatment. Delivered through video sessions with a psychologist, this therapy is easy and convenient to access. Patients have found BRIGHT acceptable, and it shows promise in addressing their body image concerns. Overall, these findings suggest that BRIGHT could effectively alleviate body image distress for head and neck cancer survivors.12678
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had curative surgery for head and neck cancer within the last year, are now cancer-free, and experience significant body image distress. They must not be planning major surgeries during the study and should not have severe psychiatric issues or ongoing cognitive behavioral therapy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either BRIGHT or Attention Control interventions delivered via video tele-cognitive behavioral therapy or tele-supportive care
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2, 3, 6, and 9 months post-randomization
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control
- BRIGHT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Cancer Institute (NCI)
Collaborator